Kuopio University Hospital

The Kuopio University Hospital, KUH Neurocenter, provides around-the-clock treatment for diseases of the central nervous system.

Neurological diseases requiring urgent treatment include cerebrovascular strokes, acute brain injury and spinal cord injury, and prolonged epileptic seizures. Multidisciplinary teams comprising experienced neurologists, neurosurgeons, and other neural specialists perform such emergency treatments.

The KUH specialty hospital provides services to patients from central and regional Finnish hospitals as well as from other parts of Finland.


KUH Neurocenter’s Expertise

KUH Neurocenter includes neurology and neurosurgery clinics, and a national epilepsy center where most of the epileptic surgery in Finland is performed. International scientific research has long been an integral part of KUH Neurocenter’s operations, and it was selected as a KUH research unit in 2018.

Research focuses on most commonly treated brain diseases, such as cerebrovascular stroke, brain degenerative diseases, epilepsy, and brain aneurysms. In addition, a long-term follow-up health economics study has been conducted for Alzheimer’s disease and microsurgery-related technological research at the Microsurgery Center founded in 2017.

The research projects of KUH Neurocenter are mainly financed by external research funding. According to the JULKI report,the KUH Neurocenter had 16,324 publications in 2014, with an aggregated impact factor (IF) of 252. The average IF for all publications was 5.7.

Neuroscience infrastructure

The KUH Neurocenter includes 5 professors, 7 docents, 17 doctors and numerous doctoral students actively engaged  in research as well as medical students. Neuroscience research is an active focus area. The research is conducted in close cooperation with the University of Eastern Finland.

Success stories

Saccular intracranial aneurysms (sIA) study

Read more

Saccular intracranial aneurysms (sIA) study

A prospective study on saccular intracranial aneurysms (sIA) has been in progress since 1990. The Aneurysm register already includes over 5,000 patients with brain aneurysms. The purpose of the study is to map the risk factors and the genetic characteristics of sIA. Based on the Aneurysm register, over 100 scientific articles have already been published.

The aim of this international study focusing on the biological mechanisms of intracranial aneurysms is to develop drug therapies and other biological treatments to prevent the formation and growth of intracranial aneurysms.


Biomarker research for epilepsy

Read more

Biomarker research for epilepsy

The epilepsy biomarker study has focused on identifying clinical, genetic, and imaging biomarkers for epilepsy. The study is collecting a large phenotype-genotype database that can be used to identify biomarkers for epilepsy in both Finnish and international collaborative projects.


Cerebrovascular stroke research

Read more

Cerebrovascular stroke research

The Cerebrovascular Stroke Study focuses on the cost-effectiveness of emerging acute therapies (fibrinolytic therapy, mechanical recanalization for thrombosis in large cerebral arteries), cerebral infarction, cerebral infarction, and rehabilitation, working closely with the University’s research teams.


Contact us

Mikael von und zu Fraunberg

  • Director, Docent of Neurosurgery
  • mikael.fraunberg@uef.fi
  • +358 50 433 5008

Juhana Frösen

  • Docent of Neurosurgery
  • juhana.frosen@kuh.fi

Anne Koivisto

  • Professor of Neurology
  • anne.koivisto@kuh.fi

Timo Koivisto

  • Deputy Director of NeuroCenter, Chief Physician of Neurosurgery, Docent
  • timo.koivisto@kuh.fi

Juha E. Jääskeläinen

  • Professor of Neurosurgery
  • juha.e.jaaskelainen@kuh.fi

Reetta Kälviäinen

  • Director of Epilepsy Center, Professor of Neurology
  • reetta.kalviainen@kuh.fi

Pekka Jäkälä

  • Director of NeuroCenter, Professor of Neurology
  • pekka.jakala@kuh.fi